| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharma | Pharmaceuticals& Drugs | 751 |
5.35 (0.72%) |
Small Cap | 6,672 | 34.3 | 8.29 | 21.7 | 2.6 | |
| Piramal Pharma | Pharmaceuticals& Drugs | 160.2 |
-3.2 (-1.96%) |
Small Cap | 5,286 | 5.3 | 13.11 | 31.1 | 2.7 | |
| Natco Pharma | Pharmaceuticals& Drugs | 883.3 |
16.15 (1.86%) |
Small Cap | 4,430 | 79.2 | 40.5 | 11 | 1.7 | |
| Emcure Pharma | Pharmaceuticals& Drugs | 1,757.3 |
33.9 (1.97%) |
Small Cap | 4,382 | 38.7 | 6.24 | 44.6 | 8.8 | |
| Aster DM Healthcare | Hospital &HealthcareServices | 788.1 |
21.5 (2.8%) |
Small Cap | 4,138 | 7.5 | 8.01 | 102.3 | 8.7 | |
| Gland Pharma | Pharmaceuticals& Drugs | 2,198.4 |
1.2 (0.05%) |
Small Cap | 4,116 | 78.8 | 26.26 | 27.9 | 3.4 | |
| JB Chem & Pharma | Pharmaceuticals& Drugs | 2,196 |
0.05 (0%) |
Small Cap | 3,890 | 42 | 17.14 | 52.3 | 8.7 | |
| Global Health | Hospital &HealthcareServices | 1,265.9 |
11.25 (0.9%) |
Small Cap | 3,204 | 18.5 | 15.48 | 68 | 8.4 | |
| Granules India | Pharmaceuticals& Drugs | 781.7 |
40.55 (5.47%) |
Small Cap | 3,030 | 16.2 | 9.87 | 45.8 | 4.2 | |
| Wockhardt | Pharmaceuticals& Drugs | 1,995 |
-27.75 (-1.37%) |
Small Cap | 3,012 | 13.1 | -1.8 | 154.3 | 6.7 | |
| Eris Lifesciences | Pharmaceuticals& Drugs | 1,433 |
22.8 (1.62%) |
Small Cap | 2,894 | 44.7 | 12.9 | 31.5 | 5 | |
| Dishman Carbogen Amc | Pharmaceuticals& Drugs | 170.5 |
2.35 (1.4%) |
Small Cap | 2,712 | 6.2 | 0.85 | 27.1 | 0.4 | |
| Aarti Drugs | Pharmaceuticals& Drugs | 371 |
3.35 (0.91%) |
Small Cap | 2,387 | 21.4 | 7.04 | 17.2 | 2.2 | |
| Alivus Life Sciences | Pharmaceuticals& Drugs | 1,059.4 |
9.65 (0.92%) |
Small Cap | 2,387 | 46 | 20.07 | 22.8 | 3.9 | |
| Dr. Lal Pathlabs | Hospital &HealthcareServices | 1,666.2 |
15.7 (0.95%) |
Small Cap | 2,352 | 30.3 | 21.21 | 54.4 | 11.2 | |
| Pfizer | Pharmaceuticals& Drugs | 4,539.4 |
38.45 (0.85%) |
Small Cap | 2,281 | 157.9 | 28.39 | 28.5 | 4.9 | |
| Strides Pharma Scien | Pharmaceuticals& Drugs | 1,107.7 |
0.55 (0.05%) |
Small Cap | 2,139 | 19.9 | 2.46 | 55.6 | 3.1 | |
| IOL Chem & Pharma | Pharmaceuticals& Drugs | 128.2 |
3.3 (2.64%) |
Small Cap | 2,079 | 4.7 | 4.59 | 26.6 | 2 | |
| FDC | Pharmaceuticals& Drugs | 383.2 |
2.4 (0.63%) |
Small Cap | 2,070 | 17.6 | 12.16 | 21.7 | 2.5 | |
| Caplin Point Lab | Pharmaceuticals& Drugs | 2,346.8 |
13.55 (0.58%) |
Small Cap | 1,937 | 84.4 | 27.17 | 27.7 | 5 | |
| Hikal | Pharmaceuticals& Drugs | 198.5 |
8.4 (4.42%) |
Small Cap | 1,860 | -4 | 4.72 | - | 2 | |
| Sanofi India | Pharmaceuticals& Drugs | 3,364.8 |
60.9 (1.84%) |
Small Cap | 1,837 | 134.5 | 18.75 | 24.6 | 9.8 | |
| Aarti Pharmalabs | Pharmaceuticals& Drugs | 659.9 |
10.85 (1.67%) |
Small Cap | 1,771 | 19.4 | 14.41 | 33.4 | 3 | |
| Unichem Lab | Pharmaceuticals& Drugs | 445.1 |
-5.1 (-1.13%) |
Small Cap | 1,736 | 22.6 | 8.09 | 19.9 | 1.2 | |
| Astrazeneca Pharma I | Pharmaceuticals& Drugs | 8,502 |
-18.6 (-0.22%) |
Small Cap | 1,716 | 75 | 10.69 | 113.6 | 24.4 |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: